+248.2%
ORCL vs ABBV
+606.4%
-358.1%
-64.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | ABBV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.0% | -0.2% | -4.8% | -5.0% |
| 7D | -0.6% | +0.4% | -1.0% | -0.7% |
| 30D | -7.1% | +3.2% | -10.3% | -7.7% |
| 3M | -20.6% | +18.8% | -39.4% | -23.7% |
| 6M | -37.8% | +41.9% | -79.7% | -43.4% |
| YTD | -38.1% | +32.8% | -70.9% | -42.8% |
| 1Y | -45.8% | +30.6% | -76.4% | -49.8% |
| 3Y | +7.6% | +135.4% | -127.8% | -18.9% |
| 5Y | +33.3% | +202.2% | -168.9% | -9.7% |
| 10Y | +248.2% | +619.3% | -371.1% | +76.8% |
| All | +248.2% | +606.4% | -358.1% | +76.8% |
Cumulative growth
Daily Returns
Daily percentage return beside ABBV.
Daily Out/Under-Performance
Portfolio return minus ABBV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ABBV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded ABBV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling